MENU
+Compare
ALXO
Stock ticker: NASDAQ
AS OF
Sep 15, 04:59 PM (EDT)
Price
$1.04
Change
-$0.02 (-1.89%)
Capitalization
56.76M

ALXO ALX Oncology Holdings Forecast, Technical & Fundamental Analysis

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials... Show more

ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALXO with price predictions
Sep 12, 2025

ALXO in -10.66% downward trend, declining for three consecutive days on September 09, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALXO declined for three days, in of 324 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ALXO moved out of overbought territory on September 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where ALXO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALXO as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALXO turned negative on September 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

ALXO broke above its upper Bollinger Band on August 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALXO advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where ALXO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALXO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.881) is normal, around the industry mean (20.731). P/E Ratio (0.000) is within average values for comparable stocks, (53.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.171). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (337.655).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALXO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALXO is expected to report earnings to fall 29.49% to -34 cents per share on November 06

ALX Oncology Holdings ALXO Stock Earnings Reports
Q3'25
Est.
$-0.35
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.20
The last earnings report on August 12 showed earnings per share of -49 cents, missing the estimate of -43 cents. With 114.89K shares outstanding, the current market capitalization sits at 56.76M.
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
72
Web
https://www.alxoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHKR0.43N/A
+0.02%
Chesapeake Granite Wash Trust
BRRDF17.40N/A
N/A
Borregaard ASA
CNDAU12.99N/A
N/A
Concord Acquisition Corp II
SAPIF24.49-0.14
-0.57%
Saputo Inc.
FFMH44.50-0.27
-0.60%
First Farmers & Merchants Corp.

ALXO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
-10.17%
MDGL - ALXO
56%
Loosely correlated
-1.65%
AXON - ALXO
45%
Loosely correlated
+0.67%
AMRN - ALXO
43%
Loosely correlated
+0.27%
ALNY - ALXO
39%
Loosely correlated
-0.57%
VERA - ALXO
36%
Loosely correlated
-3.10%
More